Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.39 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.39 |
| ▸ | TNKS | O95271 | 2/20 | 0.38 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23327832 | 0.99 | CYP1B1 (0.43) | CYP1B1CYP1A2CYP1A1SMN1; SMN2NPC1 | |
| SCHEMBL20068415 | 0.99 | CYP1B1 (0.43) | CYP1B1CYP1A2CYP1A1SMN1; SMN2NPC1 | |
| SCHEMBL31192065 | 0.99 | CYP1B1 (0.43) | CYP1B1CYP1A2CYP1A1SMN1; SMN2NPC1 | |
| SCHEMBL18017762 | 0.93 | MEN1 (0.44) | CYP1A2MEN1KMT2AATMALDH1A1 | |
| SCHEMBL18017760 | 0.93 | MEN1 (0.44) | CYP1A2MEN1KMT2AATMALDH1A1 | |
| SCHEMBL16902195 | 0.93 | MEN1 (0.44) | CYP1A2MEN1KMT2AATMALDH1A1 | |
| SCHEMBL16902239 | 0.93 | MEN1 (0.44) | CYP1A2MEN1KMT2AATMALDH1A1 | |
| SCHEMBL18017898 | 0.93 | MEN1 (0.44) | CYP1A2MEN1KMT2AATMALDH1A1 | |
| SCHEMBL18017773 | 0.93 | MEN1 (0.44) | CYP1A2MEN1KMT2AATMALDH1A1 | |
| SCHEMBL18017908 | 0.93 | MEN1 (0.44) | CYP1A2MEN1KMT2AATMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD (KR) | 2017-09-07 | — | — | US | disclosed |
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD (KR) | 2017-09-07 | — | — | US | disclosed |
| WO-2016032150-A2 | COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | 덕산네오룩스 주식회사 | 2016-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170256719-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME | ORAI2, VDAC2, PIEZO1 | CYP1B1 1915/4885CYP1A2 780/4885CYP1A1 880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.